GlassScriptPhysician profile
Ashkan Ghavami
NPI 1831393388
$23,423.42
in general payments reported to CMS, 2019-2025
17 companies · $1,643 in 2025
The $1,643 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,587 · 2020: $211 · 2021: $691 · 2022: $2,338 · 2023: $1,368 · 2024: $16K · 2025: $1,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $4,032 · Travel and Lodging: $1,267 · Long Term Medical Supply Or Device Loan: $652 · Entertainment: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,420.00 |
| Food and Beverage | $4,032.27 |
| Travel and Lodging | $1,267.19 |
| Long Term Medical Supply Or Device Loan | $651.60 |
| Entertainment | $226.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $14,800.57 | 2019-2025 | |
| Abbvie INC. | $2,577.80 | 2022-2025 | |
| Sientra, INC. | $1,497.83 | 2019-2022 | |
| Allergan, INC. | $1,231.69 | 2019-2022 | |
| Integra Lifesciences Corporation | $851.98 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Tepha INC | $610.10 | 2019-2020 | |
| Davol INC. | $484.86 | 2022-2023 | Phasix Mesh |
| Merz North America, INC. | $249.70 | 2021-2023 | Xeomin |
| Polynovo North America LLC | $205.36 | 2024 | Novosorb Btm |
| Galderma Laboratories, L.P. | $194.18 | 2019-2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $175.77 | 2019-2025 | |
| Tela Bio, INC. | $162.00 | 2022 | |
| Bard Peripheral Vascular, INC. | $100.50 | 2021 | |
| Vifor Pharma, INC. | $96.83 | 2022 | |
| Stryker Corporation | $83.84 | 2024 | Clarifix Cryotherapy Device, Medline Industries, INC., Xpress Loprofile |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $78.85 | 2024 | Daxxify |
| Aerin Medical INC. | $21.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashkan Ghavami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.